GreenMark Biomedical Inc.

Biotech East Lansing, MI

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
East Lansing, MI
Street
325 E. Grand River Avenue
Zip
48823-4375

Offering

Total offering
$5M
Amount sold
$0
First sale
—
Min investment
$25k
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
0

How this filing compares

Ranked #17 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 1.7× the median.

Other Michigan filings this week: Swarm Defense Technologies, Inc., Food Capital Partners Holdings LLC, O2 Atlas Paving Holdings, LLC, Sygaldry Technologies, Inc., W Silverbell LLC

Leadership

Steven Bloembergen PhD — Executive Officer (also: Director)

Joerg Lahann, PhD — Director

Michael Snyder — Director

Filing details

GreenMark Biomedical Inc. filed a Form D with the SEC on April 14, 2026.

Other newest Biotech companies

Other newest companies in Michigan